The antimicrobial resistance crisis: Causes, consequences, and management

Frontiers in Public Health

Volumn 2, Issue SEP, 2014, Pages

  Michael, Carolyn Anne ^a   Dominey Howes, Dale ^b   Labbate, Maurizio ^a,c  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Antibiotic; Antimicrobial resistance; Global crisis; Horizontal gene transfer; Public perception

Indexed keywords

EID: 84925341463     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2014.00145     Document Type: Review

References (50)

1. Green JL, Holmes AJ, Westoby M, Oliver I, Briscoe DA, Dangerfield M. Spatial scaling of microbial eukaryote diversity. Nature (2004) 432:747-50. doi:10.1038/nature03034
2. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A (1998) 95:6578-83. doi:10.1073/pnas.95.12.6578
3. D'Costa VM, King CE, Kalan L, Morar M, Sung WW, Schwarz C, et al. Antibiotic resistance is ancient. Nature (2011) 477:457-61. doi:10.1038/nature10388
4. Moellering RC. Discovering new antimicrobial agents. Int J Antimicrob Agents (2011) 37:2-9. doi:10.1016/j.ijantimicag.2010.08.018
5. Sykes R. The 2009 Garrod Lecture: the evolution of antimicrobial resis-tance: a Darwinian perspective. J Antimicrob Chemother (2010) 65:1842-52. doi:10.1093/jac/dkq217
6. Mazel D. Integrons and the origin of antibiotic resistance gene cassettes. ASM News (2004) 70(11):520-5.
7. Dondorp AM, Fairhurst RM, Slutsker L, MacArthur JR, Breman JG, Guerin PJ, et al. The threat of artemisinin-resistant malaria. N Engl J Med (2011) 365(12):1073-1075. doi:10.1056/NEJMp1108322
8. World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance (2014). Available from: http://www.who.int/drugresistance/ documents/surveillancereport/en/
9. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States (2013). Available from: http://www.cdc.gov/drugresistance/ threat-report-2013/pdf/ar-threats-2013-508.pdf
10. Smith RD,Keogh-BrownMR, Barnett A. Social estimating the economic impact of pandemic infiuenza: an application of the computable general equilibrium model to the problem. Soc Sci Med (2011) 73:235-44. doi:10.1016/j.socscimed. 2011.05.025
11. Moore-Gillon J.Multidrug-resistant tuberculosis: this is the cost. Ann N Y Acad Sci (2001) 953:233-40.
12. Trilla A, Trilla G,Daer C. The 1918 "Spanish fiu" in Spain. Clin Infect Dis (2008) 47:668-73. doi:10.1086/590567
13. Gogarten JP, Doolittle WF, Lawrence JG. Prokaryote evolution in light of gene transfer.Mol Biol Evol (2002) 19(12):2226-38. doi:10.1093/oxfordjournals. molbev.a004046
14. Woese CR. A new biology for a new century. Microbiol Mol Biol Rev (2004) 68(2):173-86. doi:10.1128/MMBR.68.2.173-186.2004
15. Gillings MR. Integrons: past, present, and future.MicrobiolMol Biol Rev (2014) 78(2):257-77. doi:10.1128/MMBR.00056-13
16. Michael CA, Gillings MR, Holmes AJ, Hughes L, Andrew NR, Holley MP, et al. Mobile gene cassettes: a fundamental resource for bacterial evolution. Am Nat (2004) 164(7):1-12. doi:10.1086/421733
17. Baharoglu Z, Garriss G, Mazel D. Multiple pathways of genome plasticity leading to development of antibiotic resistance. Antibiotics (2013) 2:288-315. doi:10.3390/antibiotics2020288
18. Cambray G, Sanchez-Alberola N, Campoy S, Guerin E,Da Re S, González-Zorn B, et al. Prevalence of SOS-mediated control of integron integrase expression as an adaptive trait of chromosomal and mobile integrons. Mob DNA (2014) 2011(2):6. doi:10.1186/1759-8753-2-6
19. United Nations Population Division. The World at Six Billion (2014). Available from: http://www.un.org/esa/population/publications/sixbillion/sixbilpart1. pdf
20. United Nations Humans Settlement Program. State of the World's Cities (2012/2013). London: UN-HABITAT Earthscan (2013). 207 p.
21. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a pop-ulation perspective. Emerg Infect Dis (2002) 8:4. doi:10.3201/eid0804.010312
22. Wright GD. Antibiotic resistance in the environment: a link to the clinic? Curr Opin Microbiol (2010) 13:589. doi:10.1016/j.mib.2010.08.005
23. Baquero F, Martínez J, Cantón R. Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol (2008) 19:260. doi:10.1016/j.copbio.2008. 05.006
24. Nesme J,Cecillon S,Delmont TO,Monier J-M,Vogel TM, Simonet P. Large-scale metagenomic-based study of antibiotic resistance in the environment. Curr Biol (2014) 24:1. doi:10.1016/j.cub.2014.03.036
25. Zhu Y-G, Johnson TA, Su J-Q, Qiao M, Guo G-X, Stedtfeld RD, et al. Diverse and abundant antibiotic resistance genes in Chinese swine farms. Proc Natl Acad Sci U S A (2013) 110(9):3435-40.
26. Kuehn BM. Excessive antibiotic prescribing for sore throat and acute bronchitis remains common. J Am Med Assoc (2013) 310(20):2135-6. doi:10.1001/jama. 2013.281452
27. Kuehn BM. IDSA: better, faster diagnostics for infectious diseases needed to curb overtreatment, antibiotic resistance. JAMA (2013) 310(22):2385-2386. doi:10.1001/jama.2013.283828
28. Cliodna AM, McNulty P, Boyle P, Nichols T, Clappison P, Davey P. The public's attitudes to and compliance with antibiotics. J Antimicrob Chemother (2007) 60(Suppl 1):i63-8. doi:10.1093/jac/dkm161
29. Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B. Clinical and bacterio-logical efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. J Antimicrob Chemother (2004) 54:515-23. doi:10.1093/jac/dkh356
30. ISCAP Study Group. Three day versus five-day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. Br Med J (2004) 328:791-796. doi:10.1136/bmj.38049.490255.DE
31. VanDuongD, Binns CW,Van Le T.Availability of antibiotics as over the-counter drugs in pharmacies: a threat to public health in Vietnam. Trop Med Int Health (1997) 2(12):1133-9. doi:10.1046/j.1365-3156.1997.d01-213.x
32. Maslowski KM, Mackay CR. Diet, gut microbiota and immune response. Nat Immunol (2011) 12:5-9. doi:10.1038/ni0111-5
33. Round JL,O'Connell RM,Mazmanian SK.Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun (2010) 34(3):J220-5. doi:10.1016/j.jaut.2009.11.007
34. Pless R. Vaccination benefits, risks and safety: the need for a complete picture. BullWorld Health Organ (2000) 78(2):219-21.
35. Muhsen K,Abed El-Hai R, Amit-Aharon A, Nehama H, Gondia M,Davidovitch N, et al. Risk factors of underutilization of childhood immunizations in ultra-orthodox Jewish communities in Israel despite high access to health care services. Vaccine (2012) 30:2109-15. doi:10.1016/j.vaccine.2012.01.044
36. Harmsen IA, Mollema L, Ruiter RAC, Paulussen TGW, de Melker HE, Kok G. Why parents refuse childhood vaccination: a qualitative study using online focus groups. BMC Public Health (2013) 13:1183. doi:10.1186/1471-2458-13-1183
37. World Health Organisation. The Evolving Threat of Antimicrobial Resis-tance: Options for Action (2012). Available from: http://whqlibdoc.who.int/ publications/2012/9789241503181_eng.pdf
38. Morse SS, Mazet JAK, Woolhouse M, Parrish CR, Carroll D, Karesh WB, et al. Prediction and prevention of the next pandemic zoonosis. Lancet (2012) 380:1956-65. doi:10.1016/S0140-6736(12)61684-5
39. Goossens H, Guillemot D, Ferech M, Schlemmer B, Costers M, van Breda M, et al.National campaigns to improve antibiotic use. Eur J Clin Pharmacol (2006) 62:373-9. doi:10.1007/s00228-005-0094-7
40. Jones KE, Patel NG, Levy MA, Storeygar A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature (2008) 451(21):990-3. doi:10.1038/nature06536
41. FDA. Phasing Out Certain Antibiotic Use in Farm Animals (2013). Avail-able from: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/ UCM378197.pdf
42. Wise R. Antimicrobial resistance: priorities for action. J Antimicrob Chemother (2002) 49:585-6. doi:10.1093/jac/49.4.585
43. Freudenberg WR. Perceived risk, real risk: social science and the art of proba-bilistic risk assessment. Science (1988) 242:44-9. doi:10.1126/science.3175635
44. Freudenberg WR. Public responses to technological risk: towards a sociologi-cal perspective. Soc Sci Q (2005) 33(3):389-412. doi:10.1111/j.1533-8525.1992. tb00381.x
45. Australian Public Service Commission. Changing Behaviour: A Public Policy Per-spective (2007). Available from: http://www.apsc.gov.au/__data/assets/pdf_file/ 0017/6821/changingbehaviour.pdf
46. Grigoryan L, Johannes GM, Burgerhof JGM, Degener JE, Deschepper R, Lund-borg C. Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study. Pharmacoepidemiol Drug Saf (2007) 16:1234-43. doi:10.1002/pds.1479
47. Slovic P. The Perception of Risk. London: Earthscan (2000). 473 p.
48. Kasperson J, Kasperson R, editors. The Social Contours of Risk.Vol 1: Publics, Risk Communication and the Social Amplification of Risk. 1st ed. London: Earthscan (2005). 356 p.
49. Bird D,Gisladottir G,Dominey-Howes D. Different communities, different per-spectives: issues affecting residents' response to a volcanic eruption in southern Iceland. Bull Volcanol (2011) 73:1209-27. doi:10.1007/s00445-011-0464-1
50. Gero A, Méheux K, Dominey-Howes D. Integrating disaster risk reduction and climate change adaptation in the Pacific. Clim Dev (2011) 3(4):310-27. doi:10.1080/17565529.2011.624791